Pan-cancer analysis and experimental validation identify ndc1 as a potential immunological, prognostic and therapeutic biomarker in pancreatic cancer
Figure 6. (A) Relationship between TMB and NDC1 expression in pan-cancer. (B) Relationship between MSI and NDC1 expression in pan-cancer. The correlation increases from purple to pink.